The mechanistic implications of gene expression studies in SSc: Insights from Systems Biology.
作者信息
Taroni Jaclyn N, Mahoney J Matthew, Whitfield Michael L
机构信息
Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Hanover NH 03755.
Department of Neurological Sciences, University of Vermont College of Medicine, Burlington VT.
出版信息
Curr Treatm Opt Rheumatol. 2017 Sep;3(3):181-192. doi: 10.1007/s40674-017-0072-0. Epub 2017 Jul 29.
Abstract
摘要
相似文献
1
The mechanistic implications of gene expression studies in SSc: Insights from Systems Biology.系统性硬化症基因表达研究的机制启示：来自系统生物学的见解
Curr Treatm Opt Rheumatol. 2017 Sep;3(3):181-192. doi: 10.1007/s40674-017-0072-0. Epub 2017 Jul 29.
2
Deciphering the Potential Pharmaceutical Mechanism of GUI-ZHI-FU-LING-WAN on Systemic Sclerosis based on Systems Biology Approaches.基于系统生物学方法解析桂枝茯苓丸治疗系统性硬化症的潜在药物机制。
Sci Rep. 2019 Jan 23;9(1):355. doi: 10.1038/s41598-018-36314-2.
3
A novel multi-network approach reveals tissue-specific cellular modulators of fibrosis in systemic sclerosis.一种新型多网络方法揭示了系统性硬化症中纤维化的组织特异性细胞调节因子。
Genome Med. 2017 Mar 23;9(1):27. doi: 10.1186/s13073-017-0417-1.
4
Compendium of skin molecular signatures identifies key pathological features associated with fibrosis in systemic sclerosis.皮肤分子特征纲要确定了与系统性硬皮病纤维化相关的关键病理特征。
Ann Rheum Dis. 2019 Jun;78(6):817-825. doi: 10.1136/annrheumdis-2018-214778. Epub 2019 Apr 5.
5
Integrative analysis of DNA methylation in discordant twins unveils distinct architectures of systemic sclerosis subsets.对不一致双胞胎的 DNA 甲基化进行综合分析揭示了系统性硬化症亚群的不同结构。
Clin Epigenetics. 2019 Apr 4;11(1):58. doi: 10.1186/s13148-019-0652-y.
6
Identification of Optimal Mouse Models of Systemic Sclerosis by Interspecies Comparative Genomics.通过种间比较基因组学鉴定系统性硬化症的最佳小鼠模型。
Arthritis Rheumatol. 2016 Aug;68(8):2003-15. doi: 10.1002/art.39658.
7
Molecular stratification and precision medicine in systemic sclerosis from genomic and proteomic data.基于基因组和蛋白质组数据的系统性硬化症分子分层与精准医学
Curr Opin Rheumatol. 2016 Jan;28(1):83-8. doi: 10.1097/BOR.0000000000000237.
8
Systematic approach to understanding the pathogenesis of systemic sclerosis.系统性硬化症发病机制的系统研究方法。
Clin Genet. 2017 Oct;92(4):365-371. doi: 10.1111/cge.12946. Epub 2017 Mar 15.
9
Undifferentiated Connective Tissue Disease at risk for systemic sclerosis (SSc) (so far referred to as very early/early SSc or pre-SSc).未分化结缔组织病有发生系统性硬化症（SSc）的风险（至今被称为早期/极早期 SSc 或 pre-SSc）。
Autoimmun Rev. 2015 Mar;14(3):210-3. doi: 10.1016/j.autrev.2014.11.002. Epub 2014 Nov 18.
10
Anti-collagen type v: a marker of early systemic sclerosis?抗胶原类型 v：早期系统性硬化症的标志物？
Adv Rheumatol. 2019 May 14;59(1):19. doi: 10.1186/s42358-019-0063-y.
引用本文的文献
1
Big data in systemic sclerosis: Great potential for the future.系统性硬化症中的大数据：未来潜力巨大。
J Scleroderma Relat Disord. 2020 Oct;5(3):172-177. doi: 10.1177/2397198320929805. Epub 2020 Jul 6.
2
Regulator combinations identify systemic sclerosis patients with more severe disease.调控组合可识别出系统性硬化症患者中疾病更严重者。
JCI Insight. 2020 Sep 3;5(17):137567. doi: 10.1172/jci.insight.137567.
本文引用的文献
1
A novel multi-network approach reveals tissue-specific cellular modulators of fibrosis in systemic sclerosis.一种新型多网络方法揭示了系统性硬化症中纤维化的组织特异性细胞调节因子。
Genome Med. 2017 Mar 23;9(1):27. doi: 10.1186/s13073-017-0417-1.
2
Integrated, multicohort analysis of systemic sclerosis identifies robust transcriptional signature of disease severity.系统性硬化症的综合多队列分析确定了疾病严重程度的强大转录特征。
JCI Insight. 2016 Dec 22;1(21):e89073. doi: 10.1172/jci.insight.89073.
3
A Functional Genomic Meta-Analysis of Clinical Trials in Systemic Sclerosis: Toward Precision Medicine and Combination Therapy.系统性硬化症临床试验的功能基因组荟萃分析：迈向精准医学与联合治疗
J Invest Dermatol. 2017 May;137(5):1033-1041. doi: 10.1016/j.jid.2016.12.007. Epub 2016 Dec 21.
4
CellMapper: rapid and accurate inference of gene expression in difficult-to-isolate cell types.细胞映射器：在难以分离的细胞类型中快速准确地推断基因表达
Genome Biol. 2016 Sep 29;17(1):201. doi: 10.1186/s13059-016-1062-5.
5
Systemic sclerosis.系统性硬化症。
Nat Rev Dis Primers. 2015 Apr 23;1:15002. doi: 10.1038/nrdp.2015.2.
6
Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients.个性化免疫监测揭示了对狼疮患者进行分层的分子网络。
Cell. 2016 Apr 21;165(3):551-65. doi: 10.1016/j.cell.2016.03.008. Epub 2016 Mar 31.
7
Molecular stratification and precision medicine in systemic sclerosis from genomic and proteomic data.基于基因组和蛋白质组数据的系统性硬化症分子分层与精准医学
Curr Opin Rheumatol. 2016 Jan;28(1):83-8. doi: 10.1097/BOR.0000000000000237.
8
Nilotinib (Tasigna™) in the treatment of early diffuse systemic sclerosis: an open-label, pilot clinical trial.尼洛替尼（达希纳™）治疗早期弥漫性系统性硬化症：一项开放标签的试点临床试验。
Arthritis Res Ther. 2015 Aug 18;17(1):213. doi: 10.1186/s13075-015-0721-3.
9
A longitudinal biomarker for the extent of skin disease in patients with diffuse cutaneous systemic sclerosis.弥漫性皮肤系统性硬皮病患者皮肤疾病严重程度的纵向生物标志物。
Arthritis Rheumatol. 2015 Nov;67(11):3004-15. doi: 10.1002/art.39287.
10
Dissecting the heterogeneity of skin gene expression patterns in systemic sclerosis.解析系统性硬化症皮肤基因表达模式的异质性。
Arthritis Rheumatol. 2015 Nov;67(11):3016-26. doi: 10.1002/art.39289.
Zotero 插件